Tumor-stroma interactions differentially alter drug sensitivity based on the origin of stromal cells
Tumor heterogeneity observed between patients has made it challenging to develop universal or broadly effective cancer therapies. Therefore, an ever-growing movement within cancer research aims to tailor cancer therapies to individual patients or specific tumor subtypes. Tumor stratification is gene...
Main Author: | Landry, Benjamin D. |
---|---|
Format: | Others |
Published: |
eScholarship@UMMS
2018
|
Subjects: | |
Online Access: | https://escholarship.umassmed.edu/gsbs_diss/1011 https://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=2021&context=gsbs_diss |
Similar Items
-
Metastatic Triple Negative Breast Cancer: The New Era of Thinking
by: Mohammed Amrallah A., et al.
Published: (2021-05-01) -
Association of FOSL1 copy number alteration and triple negative breast tumors
by: Leandro Tamião Rodrigues Serino, et al.
Published: (2019-02-01) -
Atractylenolide-I Sensitizes Triple-Negative Breast Cancer Cells to Paclitaxel by Blocking CTGF Expression and Fibroblast Activation
by: Meng Wang, et al.
Published: (2021-10-01) -
Characterizing triple negative breast cancer subpopulations for developing novel targeted therapies
by: Chan, Stefanie
Published: (2021) -
Precision Medicine and Triple-Negative Breast Cancer: Current Landscape and Future Directions
by: Fokhrul Hossain, et al.
Published: (2021-07-01)